Evaluation of the diagnostic value of Sentinel Lymph Node in patients with gastric adenocarcinoma

Document Type : Original Article


1 Nuclear Medicine Research Center, Mashhad University of Medical Sciences, Mashhad, Iran

2 Surgical Oncology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran

3 Student Research Committee, Mashhad University of Medical Sciences, Mashhad, Iran

4 Transplant Research Center, Clinical research institute, Mashhad University of Medical Sciences, Mashhad, Iran

5 Department of Pathology, Emam Reza Hospital, Mashhad University of Medical Sciences, Mashhad, Iran


Objective(s):  Sentinel lymph node biopsy (SLNB) has been proven as a safe and efficient procedure in some cancers like breast cancer and melanoma with a reduction of complications and side effects of unnecessary lymphadenectomy in many patients. However, the diagnostic value of SLNB in gastric cancer is a point of debate. This study evaluated the diagnostic value of SLNB using radiotracer and isosulphan blue dye injection in patients with Gastric Adenocarcinomas (GA).
Methods: This descriptive study was performed at Imam-Reza HOSPITAL on 39 patients diagnosed with GA with no lymphatic metastasis using two methods: the combination of radionuclide with isosulphan together (R&I) method compared with the isosulphan alone method. Lymphatic dissection was performed in all patients. The pathological results were compared between the sentinel lymph nodes (SLN) and other lymph nodes and their accordance rate was calculated.
Results: In the T1 group, the sentinel lymph node biopsy detection rate was 100% for the combination of the R&I method and 60% for the isosulphan method and the false negative rate was zero. These values respectively were 88.8% and 88.8% in the T2 group with a false negative rate of 75%. In the T3 group, the values were 100% for the combination of the R&I method and 93.7% for the isosulphan method with a false negative rate of 40%. In the combination of the R&I method, the sensitivity, specificity, and positive and negative predictive values were 57.9, 100, 100, and 69.2 percent respectively.
Conclusion: Based on the false negative rate (47.4%), SLNB by injection of isosulphan blue dye alone is not a diagnostic enough value for predicting lymph node metastasis in GA. Although, SLNB by combination of the R&I had better accuracy compared to the isosulphan alone, more studies with larger samples are needed to prove this result.


Main Subjects

  1. Kitagawa Y, Dempsey DT. Stomach. In: Brunicardi FC, Andersen DK, Billiar TR, Dunn DL, Hunter JG, Matthews JB, et al., editors. Schwartz's Principles of Surgery, 10e. New York, NY: McGraw-Hill Education; 2015.
  2. Deng JY, Liang H. Clinical significance of lymph node metastasis in gastric cancer. World journal of gastroenterology. 2014; 20(14):3967-75.
  3. Kinami S, Saito H, Takamura H. Significance of lymph node metastasis in the treatment of gastric cancer and current challenges in determining the extent of metastasis. Frontiers in oncology. 2021; 11:806162.
  4. Bogner PN, Fullen DR, Lowe L, Paulino A, Biermann JS, Sondak VK, et al. Lymphatic mapping and sentinel lymph node biopsy in the detection of early metastasis from sweat gland carcinoma. Cancer. 2003; 97(9):2285-9.
  5. Borgstein PJ, Pijpers R, Comans EF, van Diest PJ, Boom RP, Meijer S. Sentinel lymph node biopsy in breast cancer: guidelines and pitfalls of lymphoscintigraphy and gamma probe detection. Journal of the American College of Surgeons. 1998; 186(3):275-83.
  6. Cascinelli N, Belli F, Santinami M, Fait V, Testori A, Ruka W, et al. Sentinel lymph node biopsy in cutaneous melanoma: the WHO Melanoma Program experience. Annals of surgical oncology. 2000; 7(6):469-74.
  7. Rossi EC, Kowalski LD, Scalici J, Cantrell L, Schuler K, Hanna RK, et al. A comparison of sentinel lymph node biopsy to lymphadenectomy for endometrial cancer staging (FIRES trial): a multicentre, prospective, cohort study. The Lancet Oncology. 2017; 18(3):384-92.
  8. Leong SP, Pissas A, Scarato M, Gallon F, Pissas MH, Amore M, et al. The lymphatic system and sentinel lymph nodes: conduit for cancer metastasis. Clinical & Experimental Metastasis. 2022; 39(1):139-57.
  9. Tanis PJ, Nieweg OE, Valdés Olmos RA, Th Rutgers EJ, Kroon BB. History of sentinel node and validation of the technique. Breast cancer research: BCR. 2001; 3(2):109-12.
  10. Siddique M, Hassan A, Nawaz MK, Bashir H, Chaudhry MZ. Comparison between sentinel lymph node hybrid scintigraphy and blue dye technique in breast cancer patients: An institutional experience. World journal of nuclear medicine. 2020; 19(1): 21-7.
  11. Jeong O, Park YK, Ryu SY, Kim YJ. Effect of age on surgical outcomes of extended gastrectomy with D2 lymph node dissection in gastric carcinoma: prospective cohort study. Annals of surgical oncology. 2010; 17(6): 1589-96.
  12. Kiyokawa T, Hiki N, Nunobe S, Honda M, Ohashi M, Sano T, et al. Feasibility of Gastrectomy with Standard Lymph-adenectomy for Patients Over 85 Years Old with Gastric Cancer. Annals of surgical oncology. 2015; 22(12):3962-9.
  13. Sano T, Katai H, Sasako M, Maruyama K. Gastric lymphography and detection of sentinel nodes. Recent results in cancer research Fortschritte der Krebsforschung Progres dans les recherches sur le cancer. 2000; 157:253-8.
  14. Zulfikaroglu B, Koc M, Ozmen MM, Kucuk NO, Ozalp N, Aras G. Intraoperative lymphatic mapping and sentinel lymph node biopsy using radioactive tracer in gastric cancer. Surgery. 2005; 138(5):899-904.
  15. Lee HK, Yang HK, Kim WH, Lee KU, Choe KJ, Kim JP. Influence of the number of lymph nodes examined on staging of gastric cancer. The British journal of surgery. 2001; 88(10):1408-12.
  16. Cozzaglio L, Bottura R, Di Rocco M, Gennari L, Doci R. Sentinel lymph node biopsy in gastric cancer: possible applications and limits. European journal of surgical oncology: the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology. 2011; 37(1):55-9.
  17. Hayashi H, Ochiai T, Mori M, Karube T, Suzuki T, Gunji Y, et al. Sentinel lymph node mapping for gastric cancer using a dual procedure with dye- and gamma probe-guided techniques. Journal of the American College of Surgeons. 2003; 196(1):68-74.
  18. Booka E, Takeuchi H. Recent Advances in Sentinel Node Navigation Surgery for Early Gastric Cancer. Journal of gastric cancer. 2023; 23(1):159-70.
  19. Yashiro M, Matsuoka T. Sentinel node navigation surgery for gastric cancer: Overview and perspective. World journal of gastrointestinal surgery. 2015; 7(1):1-9.
  20. Akagi T, Shiraishi N, Kitano S. Lymph Node Metastasis of Gastric Cancer. 2011; 3(2): 2141-59.
  21. Yaguchi Y, Ichikura T, Ono S, Tsujimoto H, Sugasawa H, Sakamoto N, et al. How should tracers be injected to detect for sentinel nodes in gastric cancer--submucosally from inside or subserosally from outside of the stomach? Journal of experimental & clinical cancer research: CR. 2008; 27(1):79.
  22. Tangoku A, Seike J, Nakano K, Nagao T, Honda J, Yoshida T, et al. Current status of sentinel lymph node navigation surgery in breast and gastrointestinal tract. The journal of medical investigation: JMI. 2007; 54(1-2):1-18.
  23. Cheng LY, Zhong SZ, Huang ZH. Sentinel lymph node concept in gastric cancer with solitary lymph node metastasis. World journal of gastroenterology. 2004; 10(20): 3053-5.
  24. Wu CC, Ho WL, Chen CY, Liu TJ. [A study of perigastric lymph node metastasis in patients with early gastric cancer]. Journal of the Formosan Medical Association = Taiwan yi zhi. 1992; 91 Suppl 1:S39-46.
  25. Mitsumori N, Nimura H, Takahashi N, Kawamura M, Aoki H, Shida A, et al. Sentinel lymph node navigation surgery for early stage gastric cancer. World journal of gastroenterology. 2014; 20(19):5685-93.
  26. Takeuchi M, Kawakubo H, Shimada A, Matsuda S, Nakahara T, Mayanagi S, et al. Assessment of lymphatic flow based on the sentinel node concept in early gastric adenocarcinoma that satisfies expanded endoscopic resection criteria. Gastric Cancer. 2020; 23(3):531-9.
  27. Schlag PM, Bembenek A, Schulze T. Sentinel node biopsy in gastrointestinal-tract cancer. European journal of cancer (Oxford, England: 1990). 2004; 40(14):2022-32.